Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease

Journal of Clinical Apheresis

Volumn 19, Issue 4, 2004, Pages 168-173

  Kusaka, Takeshi ^a   Fukunaga, Ken ^a   Ohnishi, Kunio ^a   Kosaka, Tadashi ^a   Tomita, Toshihiko ^a   Yokoyama, Yoko ^a   Sawada, Koji ^b   Fukuda, Yoshihiro ^a   Miwa, Hiroto ^a   Matsumoto, Takayuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Fujimoto Hospital Medicine   (Japan)

Author keywords

Crohn's disease; Granulocytapheresis; Immunomodulation; Inflammatory bowel disease; Leukocytapheresis; Quality of life

Indexed keywords

CORTICOSTEROID; MESALAZINE; METRONIDAZOLE; NAFAMSTAT MESILATE; PREDNISOLONE; PREDONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CYTAPHERESIS; DISEASE ACTIVITY; ENTERIC FEEDING; FEMALE; FOLLOW UP; GRANULOCYTE; HUMAN; IMMUNOADSORPTION; IMMUNOMODULATION; MALE; MONOCYTE; MONOCYTE GRANULOCYTAPHERESIS; QUALITY OF LIFE; REMISSION;

ADULT; BLOOD CELL COUNT; CROHN DISEASE; FEMALE; GRANULOCYTES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKAPHERESIS; MALE; MONOCYTES; QUALITY OF LIFE; REMISSION INDUCTION; TIME FACTORS;

EID: 19944434322     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20023     Document Type: Article

References (8)

1. Sands BE. Crohn's disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Gastroenterology and Liver disease: Pathophysiology, diagnosis, and management, 7th ed. Philadelphia: Saunders. 2002. p 2005-2038.
2. Targan SR, Hanauer SR, Denvrter SJH, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med. 1997;337:1029-1035.
3. Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, Adachi M, Shimoyama T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;6:1334-1341.
4. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Lizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR. Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
5. Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, Kern F Jr. National cooperative Crohn's disease study: study design and conduct of the study. Gastroenterology 1979;77:829-842.
6. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004;49:565-571.
7. Irvine EJ. A quality-of-life index for inflammatory bowel disease. Can J Gastroenterol 1993;7:155-159.
8. Jutila MA, Rott L, Berg EL, Butcher EC. Function and regulation of the neutrophil MEL-14 antigen in vivo: comparison with LFA-1 and MAC-1. J Immunol 1989;143:3318-3324.